Passa al contenuto
Merck

The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB

Neuropharmacology (2017-08-15)
Thomas F Gamage, Charlotte E Farquhar, Timothy W Lefever, Brian F Thomas, Thuy Nguyen, Yanan Zhang, Jenny L Wiley
ABSTRACT

While allosteric modulators of the cannabinoid type-1 receptor (CB

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
5-Pregnen-3β-ol-20-one, ≥98%
Sigma-Aldrich
PSNCBAM-1, ≥98% (HPLC)